Guideline bundles adherence and mortality in severe sepsis and septic shock

Critical Care Medicine

Volumn 42, Issue 8, 2014, Pages 1890-1898

  Van Zanten, Arthur R H ^a   Brinkman, Sylvia ^b,c   Arbous, M Sesmu ^b,d   Abu Hanna, Ameen ^c   Levy, Mitchell M ^e   De Keizer, Nicolette F ^b,c  

^a GELDERSE VALLEI HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c National Intensive Care Evaluation (NICE) Foundation   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e BROWN UNIVERSITY   (United States)

Author keywords

adherence; bundles; guidelines; intensive care medicine; mortality; quality improvement; screening; septic shock; severe sepsis; Surviving Sepsis Campaign

Indexed keywords

GLUCOCORTICOID;

ADULT; AGED; APACHE; BUNDLE TARGET ADHERENCE; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; NETHERLANDS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESUSCITATION; SEPSIS; SEPTIC SHOCK; SEVERE SEPSIS; UNIVERSITY HOSPITAL; AGE; CLINICAL TRIAL; COMPARATIVE STUDY; HOSPITAL MORTALITY; MALE; MIDDLE AGED; PROTOCOL COMPLIANCE; SEX DIFFERENCE; SHOCK, SEPTIC; STANDARDS; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; GUIDELINE ADHERENCE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NETHERLANDS; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; SEPSIS; SEX FACTORS; SHOCK, SEPTIC;

EID: 84904728904     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000000297     Document Type: Conference Paper

References (29)

1. Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310
2. Moreno R, Afonso S, Fevereiro T: Incidence of sepsis in hospitalized patients. Curr Infect Dis Rep 2006; 8:346-350
3. Vincent JL, Sakr Y, Sprung CL, et al; Sepsis Occurrence in Acutely Ill Patients Investigators: Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med 2006; 34:344-353
4. Townsend SR, Schorr C, Levy MM, et al: Reducing mortality in severe sepsis: The Surviving Sepsis Campaign. Clin Chest Med 2008; 29:721-733, x
5. Dellinger RP, Carlet JM, Masur H, et al; Surviving Sepsis Campaign Management Guidelines Committee: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32:858-873
6. Dellinger RP, Levy MM, Carlet JM, et al: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008; 34:17-60
7. Dellinger RP, Townsend SR, Linde-Zwirble WT, et al: The Surviving Sepsis Campaign: Results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med 2010; 38:367-374
8. Ferrer R, Artigas A, Levy MM, et al; Edusepsis Study Group: Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA 2008; 299:2294-2303
9. Barochia AV, Cui X, Vitberg D, et al: Bundled care for septic shock: An analysis of clinical trials. Crit Care Med 2010; 38:668-678
10. Castellanos-Ortega A, Suberviola B, García-Astudillo LA, et al: Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: Results of a three-year follow-up quasi-experimental study. Crit Care Med 2010; 38:1036-1043
11. Jeon K, Shin TG, Sim MS, et al: Improvements in compliance with resuscitation bundles and achievement of end points after an educational program on the management of severe sepsis and septic shock. Shock 2012; 37:463-467
12. Levy MM, Artigas A, Phillips GS, et al: Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: A prospective cohort study. Lancet Infect Dis 2012; 12:919-924
13. Bakhshi-Raiez F, Peek N, Bosman RJ, et al: The impact of different prognostic models and their customization on institutional comparison of intensive care units. Crit Care Med 2007; 35:2553-2560
14. Levy MM, Fink MP, Marshall JC, et al; SCCM/ESICM/ACCP/ATS/SIS: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Defnitions Conference. Crit Care Med 2003; 31:1250-1256
15. Zimmerman JE, Kramer AA, McNair DS, et al: Acute Physiology and Chronic Health Evaluation (APACHE) IV: Hospital mortality assessment for today's critically ill patients. Crit Care Med 2006; 34:1297-1310
16. Ranieri VM, Thompson BT, Barie PS, et al; PROWESS-SHOCK Study Group: Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 2012; 366:2055-2064
17. VMS praktijkgids: Voorkomen van lijnsepsis en behandeling van ern-stige sepsis. VMS Veiligheidsprogramma 2009. Available at: http://www.vmszorg.nl/- library/5539/web-2009.0101-praktijkgids-sep-sis.pdf. Accessed March 18, 2013
18. Gelman A, Hill J: Chapter 5: Logistic regression. In: Data Analysis Using Regression and Multilevel/Hierarchical Models. Cambridge, UK, Cambridge University Press, 2007, pp 101-104
19. Tromp M, Tjan DH, van Zanten AR, et al: The effects of implementation of the Surviving Sepsis Campaign in the Netherlands. Neth J Med 2011; 69:292-298
20. Bollaert PE, Charpentier C, Levy B, et al: Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998; 26:645-650
21. Briegel J, Forst H, Haller M, et al: Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study. Crit Care Med 1999; 27:723-732
22. Annane D, Sébille V, Charpentier C, et al: Effect of treatment with low doses of hydrocortisone and fudrocortisone on mortality in patients with septic shock. JAMA 2002; 288:862-871
23. Sprung CL, Annane D, Keh D, et al; CORTICUS Study Group: Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358:111-124
24. Annane D, Bellissant E, Bollaert PE, et al: Corticosteroids in the treatment of severe sepsis and septic shock in adults: A systematic review. JAMA 2009; 301:2362-2375
25. Sligl WI, Milner DA Jr, Sundar S, et al: Safety and effcacy of corticosteroids for the treatment of septic shock: A systematic review and meta-analysis. Clin Infect Dis 2009; 49:93-101
26. Patel GP, Balk RA: Systemic steroids in severe sepsis and septic shock. Am J Respir Crit Care Med 2012; 185:133-139
27. Rivers E, Nguyen B, Havstad S, et al; Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377
28. Pearse R, Dawson D, Fawcett J, et al: Early goal-directed therapy after major surgery reduces complications and duration of hospital stay. Crit Care 2005; 9:R687-R693
29. Dellinger RP, Levy MM, Rhodes A, et al; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup: Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41:580-637